Repurposing licensed viral vaccines as anti-cancer therapeutics: Turning cold tumors hot.

de Bont DA, Reugebrink M, van Montfoort N, Kemp V

DOI: 10.1080/21645515.2026.2694180
Published: 2026 Dec
Container: Human vaccines & immunotherapeutics
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/21645515.2026.2694180,
  title = {Repurposing licensed viral vaccines as anti-cancer therapeutics: Turning cold tumors hot.},
  author = {de Bont DA and Reugebrink M and van Montfoort N and Kemp V},
  year = {2026},
  journal = {Human vaccines \& immunotherapeutics},
  doi = {10.1080/21645515.2026.2694180},
  url = {https://doi.org/10.1080/21645515.2026.2694180}
}

RIS

TY  - JOUR
TI  - Repurposing licensed viral vaccines as anti-cancer therapeutics: Turning cold tumors hot.
AU  - de Bont DA
AU  - Reugebrink M
AU  - van Montfoort N
AU  - Kemp V
PY  - 2026
JO  - Human vaccines & immunotherapeutics
DO  - 10.1080/21645515.2026.2694180
UR  - https://doi.org/10.1080/21645515.2026.2694180
ER  -

APA

DA, D. B., M, R., N, V. M., & V, K. (2026). Repurposing licensed viral vaccines as anti-cancer therapeutics: Turning cold tumors hot.. Human vaccines & immunotherapeutics. https://doi.org/10.1080/21645515.2026.2694180

Source records

pubmed · retrieved 2026-09-26T03:35:28.678Z